Sin conexión a internet: se muestra la versión guardada de la página.

Opko Health Inc

USUSD
← Al Screener

Opko Health Inc (LSE:0KCS) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
opko.com
Relaciones con los Inversores
opko.com/investors
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede Central
Miami, United States
Consejero Delegado
Phillip Frost
Empleados
2 275
Fundada
1991
Acciones en Circulación
746.33 M a 2026-07-17
Capital Flotante
323.73 M
Capitalización Bursátil
1.17 mil M USD
Insiders
50.52%
Inversores Institucionales
27.56%
Industria (SIC)
Pharmaceutical Preparations
ISIN
US68375N1037
LEI
529900A4S2D4OGOJLL02
FCF
−134 M USD
Deuda
349 M USD
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
Descripción

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksOPK principalUSD1.38 +0.00%acciones ordinarias
LSE London Stock Exchange0KCS IOBUSD1.64 +0.00%acciones ordinarias

Precio en 3 Meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Rubric Capital Managemen…6.4%47.79 M2026-06-30
Blackrock Inc.4.95%36.98 M2026-06-30
Vanguard Capital Managem…2.01%14.97 M2026-06-30
Vanguard Portfolio Manag…2%14.93 M2026-06-30
Geode Capital Management…1.55%11.58 M2026-06-30
iShares Trust-iShares Ru…1.38%10.32 M2026-08-31
State Street Corporation1.38%10.31 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.31%9.75 M2026-06-30
Goldman Sachs Group Inc0.94%7.04 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%6.92 M2026-06-30
UBS Group AG0.67%5.01 M2026-06-30
VANGUARD INDEX FUNDS-Van…0.66%4.91 M2026-06-30
Whitefort Capital Manage…0.6%4.51 M2026-06-30
Fidelity Salem Street Tr…0.58%4.35 M2026-07-31
iShares Trust-iShares Ru…0.51%3.79 M2026-08-31
Northern Trust Corporati…0.5%3.76 M2026-06-30
iShares Trust-iShares Bi…0.38%2.81 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.29%2.2 M2026-06-30
VANGUARD SCOTTSDALE FUND…0.28%2.11 M2026-05-31
SCHWAB STRATEGIC TRUST-S…0.27%2.04 M2026-05-31
PAGANELLI JOHN A (Direct…≈0.05%403 5152026-03-20
FROST PHILLIP MD ET AL (…——2025-11-21